CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Endpoints News
Original article

New CDER appointment elevates longtime GLP-1 reviewer

Neutral
AI Analysis

Summary

Lisa Yanoff, a longtime FDA staffer with expertise in metabolic drug reviews including GLP-1 medications, has been promoted to acting deputy director at the FDA's Center for Drug Evaluation and Research by acting CDER director Michael Davis.

Importance:2/10
Sentiment:
0.00
FDAPersonnelCDERGLP-1Regulatory

Read the original article

Published by Endpoints News on July 6, 2026 5:05 PM

Read Original